Non-syndromic cleft lip/palate (NSCLP), the most common human craniofacial 14 malformations, is a complex disorder given its genetic heterogeneity and multifactorial 15 component revealed by genetic, epidemiological and epigenetic findings. Association of 16 epigenetic variations with NSCLP has been made, however still of little functional investigation. 17
Introduction 27
28 Non-syndromic cleft lip/palate (NSCLP) is the most common craniofacial congenital 29 malformation in humans, affecting 1:700 live-births worldwide, and follows a multifactorial model 30 of inheritance [1] [2] [3] . Genetic contribution to NSCLP has long been supported by several 31 independent studies, which has shown heritability estimates as high as 78-91% in Asian, 32 European and Brazilian populations 4-6 . Genomic analyses have successfully revealed several 33 at-risk common genetic variants, in distinct populations. Nevertheless, they confer a small risk, 34 and explain 10-30% of the disease's heritability 7, 8 . In addition, an increasing number of rare 35 pathogenic variants has also been identified in families segregating NSCLP, but the extent of 36 their contribution in overall NSCLP cases is uncertain; importantly, no shared prevalent genetic 37 basis has been observed for these variants 9-14 , except for mutations in the Epithelial Cadherin-38 p120-Catenin Complex, which are responsible for 2-14% of familial NSCLP cases 15 . Given the 39 lack of a common mechanism underlying a large proportion of cases, projections for strategies 40 of prevention and development of predictive diagnostic tests in at-risk couples have been 41 currently hindered. 42
In parallel with genetic studies, epidemiological studies have suggested the influence of 43 several environmental factors predisposing to NSCLP [16] [17] [18] [19] [20] [21] [22] [23] . In this sense, recent progress on 44 uncovering the epigenetic contribution to NSCLP have been made [24] [25] [26] [27] . Epigenetic variations 45 (or epivariations) are dynamic, functional and inheritable covalent changes in DNA and/or 46 chromatin associated proteins which do not alter DNA sequence, yet they can affect gene 47 expression and contribute to phenotypic variability and disease [28] [29] [30] [31] [32] [33] . Association of genomic 48 epivariations to phenotypes, so called Epigenome-wide association studies (EWAS), have been 49 expanding the knowledge on phenotypic variability and disease molecular mechanisms for the 50 past years 30,31,34-41 . More recently, individual-specific methylome analysis has shed light on 51 epigenetic variation relevant to disease, demonstrating how this approach can uncover 52 the gene level comparing individually each one of the 66 NSCLP samples versus all 59 controls 79 ("450k cohort"), looking for individual epivariation. We found a total of 6620 gene DMRs 80 (average = 100.3 DMRs per sample) in all NSCLP samples with >5% methylation difference and 81 adjusted p-value<0.05 ( Supplementary Table 3 ). 82 83 mir152 was the most frequent DMR (n=17 NSCLP samples; ~26%) with ~6% of 84 average hypomethylation difference (beta-value reduction) in comparison to controls and was 85 not present in previous published data on common epivariation 42 . 86 87 mir152 methylation validation in other cohorts 88 89
To validate the previous findings, we investigated mir152, 8q24.21 and 1p36.13 DMRs in 90 an independent Brazilian cohort of 57 NSCLP samples and 130 control samples, using a 91 different method for DNA methylation quantification (BSAS). 8q24.21 and 1p36.13 DMRs were 92 included in the validation step as both regions have been associated with NSCLP 7,55,56 . We 93 observed no correlation of potential confounding factors (bisulfite conversion batch, PCR batch, 94 age, sex or origin; Supplementary Figure 1a Fisher's Exact Test). Also, when we considered each CpGs within mir152 DMR independently, 118 we found hypomethylation enrichment at CpG 3 (18%), CpG 4 (14%), CpG 5 (16%), CpG 6 119 (21%) and the adjacent CpG 7 (12%). Correlation analysis of methylation levels from all 9 120 mir152 CpGs revealed a trend of hypomethylation shared by CpGs 4, 5, 6 and 7 and mild 121 correlation values ( Supplementary Figure 2a -b), which could be indicative of a more cohesive 122 methylation block at those sites. Taken together, our results corroborate mir152 123 hypomethylation in both Brazilian NSCLP cohorts. 124
Attempting to evaluate mir152 methylation contribution to NSCLP in an independent and 125 different population, we looked for other NSCLP methWAS available data. Using summary 126 statistics data from an available NSCLP case-control methWAS performed on 182 hispanic and 127 non-hispanic samples (94 NSCLP and 88 controls 27 ), we did not found significant differences 128 coincides with CpG site 8 at mir152 DMR, which displays low methylation levels in both NSCLP 139 and control samples (NSCLP average beta-value= 0.0178, controls average beta-140 value=0.0121). Even though rs12940701 has been suggested as a potential variant diminishing 141 methylation levels at mir152 region 59 , we observed no genotype vs. methylation correlation in 142 our replication cohort (p=0.1843, Supplementary Figure 2d ). Also, we found no linkage 143 disequilibrium between this SNV and rs1838105, a 1.3Mb apart SNV previously associated with 144 NSCLP at 17q21.32 (Yu et al., 2017 ; Supplementary Figure 2c ). Rare variants (minor allele 145 frequency < 0.5%) at mir152 gene were not analysed in this cohort (data not shown). Attempting 146 to verify whether rare variants at mir152 region could segregate in independent NSCLP familial 147 cases, we analysed the exome of 36 affected individuals from 11 families , but neither common 148 nor rare variants were found. 149 150
Methylation variation at mir152 regulates gene expression 151 152
We next verified whether methylation variation within mir152 DMR would be functional 153 and interfere in mir152 expression. To achieve that, we carried out a CRISPR-Cas9-based 154 approach for targeted demethylation, in which dCas9 were fused to TET1 (pPlatTET-GFP) in 155 order to demethylate specific genomic targets 48 . Among the three tested sgRNAs (sgRNA-1, 156 sgRNA-2 and sgRNA-3) targeting the mir152 DMR in hek293T cells, sgRNA-3 efficiently 157 reduced methylation levels at mir152 DMR at sites 1, 4, 5 and 8 (average beta-value pPlatTET-158 sgRNA-3 = 0.54, beta-value pPlatTET-NC= 0.76, beta-value NC =0.80; Figure 2a ). In non-159 transfected conditions, or when transfected with the empty vector (pPlatTET-NC) or sgRNAs-1 160 and 2, hek293T do not normally express mir152. On the other hand, consistently with those 161 methylation changes, we observed a high upregulation of mir152 RNA levels when sgRNA-3 162 transfections were carried out ( Figure 2b ). Taken together, those results indicate that 163 epivariation at those sites are functional, resulting in mir152 expression changes. 164 However, when injected with mimics, zebrafish embryos presented several craniofacial defects 181 at 5dpf including malformation of Meckel's, palatoquadrate, ceratobranchial and the ethmoidal 182 plate, which is the embryo's analogue palate. Seventy percent (70%) of embryos were affected, 183 which were classified as mildly affected (28,5%), comprising those embryos with ethmoidal 184 plate's defects in size and shape, and severely affected (41,5%), characterized by a typical cleft 185 at the ethmoidal plate. (Figure 3a ). On the other hand, co-injection of mir152 mimics and inhibitor 186 led to non-affected embryos (n= 65) ( Figure 3a) . 187 188 mir152 targets dnmt1 and cdh1 in zebrafish neural crest cells 189 190 Several coding genes are predicted to be targeted by mir152, including DNMT1, which 191 has been experimentally confirmed [59] [60] [61] [62] . In that case, mir152 is known to control a 192 DNMT1/CDH1 loop, in which mir152 upregulation leads to DNMT1 downregulation and as a 193 consequence CDH1 expression is present 60 . Therefore, we checked for DNMT1 and CDH1 194 expression differences in pPlatTET-GFP transfected hek293T cells or mimics/ inhibitor injected 195 zebrafish embryos. We did not observed DNMT1/dnmt1 or CDH1/cdh1 expression changes in 196 any sgRNA transfected hek293T cells or in mir152 mimics/ inhibitor injected zebrafish whole 197 embryos RNA ( Supplementary Figure 3 ). Because whole embryo expression could mask tissue-198 specific changes and given the extent of observed craniofacial impairment in injected embryos 199 we hypothesized that neural crest cells (NCCs) would be the most likely cells to be affected by 200 mir152 dysregulation. To test that, mir152 mimics/ inhibitor injected embryos were dissociated 201 at 24hpf and sox10-GFP positive were sorted for dnmt1 and cdh1 expression analysis. We 202 observed an ablation of dnmt1 and cdh1 expression in sox10-GFP positive cells when mir152 203 mimics was injected and no effects on dnmt1 or cdh1 expression in inhibitor or mimics+inhibitor 204 injections ( Figure 3b hypoxia is a known clefting factor in mice and has also been reported to induce ethmoid plate 230 defects in zebrafish 63-65 . We then hypothesised hypoxia as an environmental factor leading to 231 mir152 hypomethylation, which in turn would cause up-regulation of mir152, resulting in 232 craniofacial malformation. We then first exposed zebrafish embryos to hypoxia (1% O2) for 24h 233 or 48h and obtained 5dpf embryos with reduced ethmoid plate size (Figure 3c ). By quantifying 234 mir152 levels in such conditions, we observed that hypoxia induced a significant up-regulation 235 of mir152 in comparison to normoxia (up to ~20 fold, Figure 3d ). mir152 methylation changes in 236 hypoxia were also tested and we observed hypomethylation of mir152 methylation levels from 237 80% at normoxia conditions, 100% at hypoxia for 24h and 66% at hypoxia for 48h ( Figure 3d ). 238
Therefore we consider that hypoxia was capable of reducing mir152 methylation at least in 14% 239 for a 48h hypoxia treatment. By reanalyzing previously published data, we were able to identify mir152 as a new 253 candidate NSCLP gene in up to 26% of NSCLP samples with DMR hypomethylated. e also 254 confirmed hypomethylation of mir152 in 15%-21% of NSCLP samples in an independent 255 Brazilian cohort. These findings corroborate our initial findings and suggests a common 256 epivariation at mir152 for NSCLP, which is one of the most frequent alteration so far associated 257 with NSCLP, at least in our population. We also found significant mir152 promoter methylation 258 differences using methWAS data from a different population 27 , which suggest that not only 259 epivariation at mir152 gene body could be associated with NSCLP but also at the promoter 260 region. We believe therefore that epivatiation at mir152, both at promoter or gene body, is 261 associated with NSCLP. We could not replicate, however, 8q24.21 or 1p36.13 DMRs in this 262 independent cohort. Methylation differences at 8q24 in NSCLP have been previously reported 263 27 , although in a different region than 8q24.21 DMR, more specifically at 8q24.23 HEATR7A. 264 Therefore we do not know whether such methylation changes at 8q24 are dependent on each of 265 the studied population or their effects are smaller for detection in our independent cohort. 266 mir152 is a member of the mir148/mir152 family and is located within an intron of 267 COPZ2 at chromosome 17q21.32, a genomic region previously associated with NSCLP by 268 GWAS, however with WNT9B as the principal candidate gene 7 . Attempting to identify if mir152 269 variation could add to the NSCLP GWAS signals at 17q21.32, we also looked at LD data from 270 1000 genomes and found that both genes were not in LD. Still, we here show that regions 271 previously associated with NSCLP by genetic approaches can also be prone to epigenetic 272 changes as previously reported 27 . 273
Because genetic variation can modulate DNA methylation within a region 57,69,70 , we 274 investigated whether common genetic variation could modulate methylation changes at mir152. 275
Our results suggested that neither common nor rare variants at mir152 region contribute to 276 mir152 epivariation as a methylation QTL (meQTL) in the cohort here studied. In fact, mir152 277 processed sequence is highly conserved and identical from fish to mammals 71 , indicating that 278 either its function has been conserved during evolutionary diversification and/or genetic 279 variation at that region is not tolerated. We cannot rule out that genetic variation in the promoter 280 region of mir152 or out of the analysis region, which is not covered in our Sanger sequencing 281 and exome analysis, could lead to expression variability. Further, we also cannot exclude that 282 other tissues than the here studied could display a meQTL status for rs12940701. 283
284
To determine the functional effects of mir152 hypomethylation in gene expression, we 285 induced a cas9-mediated demethylation of mir152 in hek293T cells, and showed that mir152 286 hypomethylation leads to mir152 upregulation in human cells. Importantly, the major methylation 287 changes were made at CpGs 4 and 5, the core of mir152 DMR, which coincides with the CpG 288 sites bearing higher methylation correlation. Therefore the findings on mir152 hypomethylation 289 at both 450K and the independent cohorts are likely functional. 290
Once we found mir152 hypomethylation to promote mir152 upregulation, we mimetized 291 mir152 upregulation in zebrafish development by mir152 mimics injections. mir152 upregulation 292 led to several craniofacial defects compatible with clefting phenotypes, grouped in two severity 293 degrees:: mid-affected and severely-affected zebrafish larvae at 5dpf. We speculate that the 294 extension of those phenotypes are dose dependent, because micro-injection of zebrafish 295 embryos can vary in precision of oligonucleotides incorporation by the embryo cells. It is 296 important to note that such observed phenotype were specific to mir152-mimics injection, 297 compatible with a mir152 upregulation scenarium, once both inhibitor and mimics + inhibitor 298 injections resulted in no affected embryos. 299
Functional studies have demonstrated mir152 as an important modulator of TGFbeta-300 induced EMT in epithelial cells, in which mir152 overexpression is known to inhibit TGFbeta and 301 therefore EMT 72 . It has also been shown that upregulation of mir152 targets DNMT1, which in 302 turn controls CDH1 expression via DNA methylation and therefore affecting E-cadherin levels 303 and EMT in breast cancer cells 60 . Interestingly, CDH1/E-cadherin loss-of-function mutations 304 have been found in both syndromic and nonsyndromic clefting forms and CDH1 promoter 305 hypermethylation have been found in association with cleft penetrance in NSCLP families 13,24,73 . 306 In this study, We observed a reduction of both dnmt1 and cdh1 expression in mir152 307 mimics-injected sox10-GFP NCCs suggesting that this control can be specific at certain cell 308 types, more specifically NCCs. Even more interestingly and opposite to what has been 309 described by other works, which reported mir152 upregulation accompanied by dnmt1 310 downregulation and cdh1 upregulation, we found total reduction of cdh1 expression when 311 mir152 mimics was injected. We do not know if this effect is related to dnmt1 or to other targets 312 of mir152 in this cell population; nevertheless loss of CDH1 expression is compatible with CDH1 313 related molecular pathology in NSCLP families 13,73,74 and cdh1 downregulation in NCCs has 314 been reported to inhibit NCC migration in Xenopus 75 . Therefore, given the effects of mir152 we first compared all 66 NSCLP samples versus all 59 controls (450K cohort) using the 371 RnBeads pipeline, which comprises filtering, normalisation and differential methylation steps 43 . 372
We filtered out probes affected by SNPs, on sex chromosomes, probes with a p-value detection 373 >0.05 (Greedycut) and probes with non-CpG methylation pattern. Data was normalised using 374 the SWAN method. Principal component analysis (PCA) were also performed using R packages 375 in order to identify obvious confounding effects in the 450K cohort. Differential methylation 376 analysis was performed using the RefFreeEWAS method, which corrects p-values for blood 377 cellular contributions, accounting for gene regions. We also used sex, age and probe markers of 378 batch effects as covariates for differential methylation analysis p-value correction as previously 379 described 24 . We used as selection criteria the 5 top ranked DMRs listed by RnBeads, which 380 ranks DMRs combining adjusted p-values, methylation difference and quotient of difference. As 381 a second step to identify individual contributions to the selected DMRs, we conducted analysis 382 individually comparing each NSCLP sample versus all 59 controls using the same parameters 383 above described. At this phase, =we selected as DMRs those regions with p-value < 0.05 after 384 FDR and covariate adjustment and with at least 5% beta-value difference. We also compared 385 those DMRs with previously published data of frequent and common DMRs 42 . DMRs were 386 listed by NSCLP sample and we checked for DMRs co-occurring in different NSCLP samples. 387
388
Bisulfite amplicon sequencing of mir152 in the replication cohort 389 390 To quantify methylation levels at mir152, 8q24.21 and 1p26.13 DMRs in the replication 391 cohort, we used the Bisulfite Amplicon Sequencing (BSAS) method as previously described 24 . 392
In summary, BSAS relies on bisulfite PCR, library preparation and DNA sequencing with a NGS 393 sequencer 44, 45 . We designed bisulfite-specific PCR primers for those DMRs using the online 394 tool MethPrimer (http://www.urogene.org/methprimer/) with reported recommendations to avoid 395 biased bilsufite PCR amplification 46 MiSeq Sequencer (Illumina). We performed de-multiplexing of sequences using the FASTX 412
Barcode
Splitter program in the FastX Toolkit R package 413 (http://hannonlab.cshl.edu/fastx_toolkit/). Following this, we filtered out reads of low quality, 414 selecting only reads with at least 50% of bases with Q > 30 using the FASTQ Quality Filter 415 program, also part of the FastX Toolkit R package. Next FASTQ files were converted to FASTA 416 files using the FASTQ-to-FASTA program in the same package. For the quantification of 417 methylation levels at the mir-152 region we used the BiQAnalyzer HT software 47 , in which we 418 applied quality filters as follows: minimal reference sequence identity to 90%, minimal bisulfite 419 conversion rate of 90%, maximum of 10% gaps allowed in CpG sites and minimal of 10 reads of 420 coverage. Following these parameters, we obtained average mir152 region methylation level 421 per sample and also site methylation level within mir152 region. To investigate hypomethylation, 422 we calculated the controls' 10th percentile and computed NSCLP samples below this limiar. 423
Frequencies were tested by expected in controls and observed in NSCLP using Chi-square test. 424
Graphs were generated using R package ggplot2. To functionally investigate the role of methylation variation at the mir152 DMR, we used 462 a CRISPR-Cas9 based approach in which a plasmid expressing a modified and catalytically 463 inactive Cas9 (dCas9) were fused to the catalytic domain of TET1 with a co-expression system 464 for sgRNA, allowing target specific demethylation 48 . We obtained plasmid pPlatTET-gRNA2 465 (#82559) from Addgene. mir152 specific sgRNAs were designed with CRISPRdirect 466 (https://crispr.dbcls.jp/), named as sgRNA-1 (5'-TCTGTGATACACTCCGACTC-3'), sgRNA-2 467 (5'-GCTCGGCCCGCTGTCCCCCC-3') and sgRNA-3 (5'-TGACAGAACTTGGGCCCGGA-3'). 468 sgRNAs were cloned to plasmids as previously published 48 . All the three plasmid-sgRNA 469 combinations plus empty plasmids were transfected to hek293T cells with SuperFect (QIAgen) For mir152 methylation analysis after pPlatTET1-GFP plasmid transfections in hek293T 505 cells, we applied traditional bisulfite sequencing method, consisted of bisulfite conversion of 1ug 506 of genomic DNA and PCR amplification of mir152 region using the method above described. 507 PCR products cloning into pGEM-T-easy vector system (Promega). We Sanger sequenced 10 508 colonies per sample using M13 primers using the above described method and results were 509 analysed with BISMA online tool (Bisulfite Sequencing DNA Methylation Analysis -510 http://services.ibc.uni-stuttgart.de/BDPC/BISMA/) 50 with default parameters. 511 512
Injection of mirna mimics and inhibitor in zebrafish embryos and hypoxia tests 513 514
We performed crossings of both AB and sox10-GFP zebrafish lineages and embryos 515 were collected in E3 medium. Specific Mirna mimics and inhibitor for mir152 were purchased 516 from mirVana Thermofisher Scientific. Embryos at the 1-cell stage were injected with 2nl of 517 25uM dre-mir152 mimics, 25uM dre-mir152 inhibitor, 25uM dre-mimics + inhibitor or TE. 518
Injected embryos were then raised for up to 5 days in E3 medium at 29oC and 12h/12h 519 light/dark cycle. 24hpf injected embryos were collected for RNA extraction and subsequent 520 cDNA synthesis and RTqPCR following the protocols above mentioned, for confocal microscopy 521 imaging or for cell dissociation followed by GFP-positive cell sorting. Pools of 20 embryos at 522 24hpf were used for cell dissociation following published methods 51 and GFP-positive cells 523 were sorted using BD FACS Aria II and BD FACS Diva software. Larvae at 5dpf were collected 524 and fixed in 4% PFA followed by alcian blue staining for craniofacial cartilages phenotyping 525 using previously published protocols 52 . To study hypoxia effects on zebrafish embryos, we 526 exposed 1-cell stage zebrafish embryos for 24h or 48h in a 1% O2 incubator (Hera Cell -527 ThermoFisher). 528 529 Acknowledgements 530
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